OBJECTIVE: To study the proper way of using combined postoperative chemo-radiotherapy and prognostic factors of soft tissue sarcoma. METHODS: The clinical data of 184 patients were retrospectively reviewed. These patients were devided into surgery group (S, 94 patients), surgery plus postoperative radiotherapy group (S + R, 62 patients) and surgery plus chemotherapy group (S + C, 28 patients). RESULTS: The 5-year survival rates of S, S + R and S + C groups were 39.4%, 48.4% and 28.6%, respectively. Combined multitherapy was the key to improve survival rate and life quality. Clinical stage, pathological type and therapeutic method were also important prognostic factors for the long term survival. CONCLUSION: Surgery plus postoperative radiotherapy can improve the 5-year survival rate of soft tissue sarcoma.